CEBPD Reverses RB/E2F1-Mediated Gene Repression and Participates in HMDB-Induced Apoptosis of Cancer Cells

Purpose: Recent evidence indicates that a tumor suppressor gene CEBPD (CCAAT/enhancer-binding protein delta) is downregulated in many cancers including cervical cancer, which provides a therapeutic potential associated with its reactivation. However, little is known for CEBPD activators and the effect of reactivation of CEBPD transcription upon anticancer drug treatment. In this study, we identified a novel CEBPD activator, 1-(2-hydroxy-5-methylphenyl)-3-phenyl-1,3-propanedione (HMDB). The purpose of this study is to characterize the mechanism of HMDB-induced CEBPD activation and its potential effect in cancer therapy. Experimental Design: Methylation-specific PCR assay, reporter assay, and chromatin immunoprecipitation (ChIP) assay were performed to dissect the signaling pathway of HMDB-induced CEBPD transcription. Furthermore, a consequence of HMDB-induced CEBPD expression was linked with E2F1 and retinoblastoma (RB), which discloses the scenario of CEBPD, E2F1, and RB bindings and transcriptional regulation on the promoters of proapoptotic genes, PPARG2 and GADD153. Finally, the anticancer effect of HMDB was examined in xenograft mice. Results: We demonstrate that CEBPD plays an essential role in HMDB-mediated apoptosis of cancer cells. HMDB up-regulates CEBPD transcription through the p38/CREB pathway, thus leading to transcriptional activation of PPARG2 and GADD153. Furthermore, increased level of CEBPD attenuates E2F1-induced cancer cell proliferation and partially rescues RB/E2F1-mediated repression of PPARG2 and GADD153 transcription. Moreover, HMDB treatment attenuates the growth of A431 xenografts in severe combined immunodeficient mice mice. Conclusions: These results clearly demonstrate that HMDB kills cancer cells through activation of CEBPD pathways and suggest that HMDB can serve as a superior chemotherapeutic agent with limited potential for adverse side effects. Clin Cancer Res; 16(23); 5770–80. ©2010 AACR.

[1]  G. P. Studzinski,et al.  Enhancement by other compounds of the anti-cancer activity of vitamin D(3) and its analogs. , 2004, Experimental cell research.

[2]  D. Ramji,et al.  CCAAT/enhancer-binding proteins: structure, function and regulation. , 2002, The Biochemical journal.

[3]  N. L. Thangue,et al.  The yin and yang of E2F-1: balancing life and death , 2003, Nature Cell Biology.

[4]  J. O’Rourke,et al.  CCAAT/Enhancer-binding Protein-δ (C/EBP-δ) Is Induced in Growth-arrested Mouse Mammary Epithelial Cells* , 1997, The Journal of Biological Chemistry.

[5]  C. Lieber,et al.  Alcohol, vitamin A, and beta-carotene: adverse interactions, including hepatotoxicity and carcinogenicity. , 1999, The American journal of clinical nutrition.

[6]  B. Wouters,et al.  Apoptosis, p53, and tumor cell sensitivity to anticancer agents. , 1999, Cancer research.

[7]  W. Hofmann,et al.  The C/EBPδ tumor suppressor is silenced by hypermethylation in acute myeloid leukemia , 2007 .

[8]  S. McKnight,et al.  Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. , 1995, Genes & development.

[9]  Dong Wang,et al.  Cellular processing of platinum anticancer drugs , 2005, Nature Reviews Drug Discovery.

[10]  R. Schild,et al.  The kinase p38 regulates peroxisome proliferator activated receptor-gamma in human trophoblasts. , 2006, Placenta.

[11]  R. Schild,et al.  The kinase p38 Regulates Peroxisome Proliferator Activated Receptor-γ in Human Trophoblasts , 2006 .

[12]  M. Raffeld,et al.  C/EBPδ is a crucial regulator of pro-apoptotic gene expression during mammary gland involution , 2005, Development.

[13]  G. D. De Zutter,et al.  Pro-apoptotic gene expression mediated by the p38 mitogen-activated protein kinase signal transduction pathway , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Valeria Poli,et al.  The Role of C/EBP Isoforms in the Control of Inflammatory and Native Immunity Functions* , 1998, The Journal of Biological Chemistry.

[15]  M. Barbacid,et al.  Cdk4 promotes adipogenesis through PPARgamma activation. , 2005, Cell metabolism.

[16]  W. Du,et al.  Retinoblastoma family genes , 2006, Oncogene.

[17]  S. Gery,et al.  CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells. , 2005, Cancer research.

[18]  R. Egeler,et al.  Dexamethasone increases hepatotoxicity of MTX in children with brain tumors. , 1998, Anticancer research.

[19]  Jesse D. Martinez,et al.  Activator protein-1 and CCAAT/enhancer-binding protein mediated GADD153 expression is involved in deoxycholic acid-induced apoptosis. , 2002, Biochimica et biophysica acta.

[20]  R. Glazer,et al.  Inhibition of peroxisome proliferator-activated receptor gamma increases estrogen receptor-dependent tumor specification. , 2009, Cancer research.

[21]  H. Harada,et al.  p38‐MAP kinase activation followed by BIM induction is essential for glucocorticoid‐induced apoptosis in lymphoblastic leukemia cells , 2006, FEBS letters.

[22]  Laith F. Gulli,et al.  Epidermal growth factor-induced apoptosis in A431 cells can be reversed by reducing the tyrosine kinase activity. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[23]  Y. Chen,et al.  Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. , 1996, Genes & development.

[24]  W. Hofmann,et al.  C/EBPδ expression in a BCR-ABL-positive cell line induces growth arrest and myeloid differentiation , 2005, Oncogene.

[25]  A. Porras,et al.  p38 MAP kinases: beyond the stress response. , 2000, Trends in biochemical sciences.

[26]  E V Maytin,et al.  Stress-inducible transcription factor CHOP/gadd153 induces apoptosis in mammalian cells via p38 kinase-dependent and -independent mechanisms. , 2001, Experimental cell research.

[27]  Ji-Hyung Seo,et al.  Elevated gadd153/chop expression during resveratrol-induced apoptosis in human colon cancer cells. , 2007, Biochemical pharmacology.

[28]  Lei-Chin Chen,et al.  Functional role of NF-IL6β and its sumoylation and acetylation modifications in promoter activation of cyclooxygenase 2 gene , 2006, Nucleic acids research.

[29]  T. Ried,et al.  Loss of CCAAT/enhancer binding protein δ promotes chromosomal instability , 2004, Oncogene.

[30]  J. T. Tseng,et al.  Induction of human NF-IL6beta by epidermal growth factor is mediated through the p38 signaling pathway and cAMP response element-binding protein activation in A431 cells. , 2005, Molecular biology of the cell.

[31]  J. Bertino,et al.  Fas-mediated signaling enhances sensitivity of human soft tissue sarcoma cells to anticancer drugs by activation of p38 kinase. , 2002, Molecular cancer therapeutics.

[32]  M. Blagosklonny,et al.  P53: An ubiquitous target of anticancer drugs , 2002, International journal of cancer.

[33]  J. Dewille,et al.  Promoter methylation reduces C/EBPδ (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors , 2005, Breast Cancer Research and Treatment.

[34]  W. Kruger,et al.  Suppression of Tumor Formation by a Cyclooxygenase-2 Inhibitor and a Peroxisome Proliferator-Activated Receptor γ Agonist in an In vivo Mouse Model of Spontaneous Breast Cancer , 2008, Clinical Cancer Research.

[35]  J. Kato,et al.  Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1 , 1999, Nature.

[36]  Xiaozhong Wang,et al.  Stress-Induced Phosphorylation and Activation of the Transcription Factor CHOP (GADD153) by p38 MAP Kinase , 1996, Science.

[37]  W. Hofmann,et al.  The C/EBPdelta tumor suppressor is silenced by hypermethylation in acute myeloid leukemia. , 2007, Blood.

[38]  S. Sell,et al.  Stem cell origin of cancer and differentiation therapy. , 2004, Critical reviews in oncology/hematology.

[39]  C. Tei,et al.  Antiproliferative effects of gefitinib are associated with suppression of E2F-1 expression and telomerase activity. , 2006, Anticancer research.

[40]  T. Ried,et al.  Loss of CCAAT/enhancer binding protein delta promotes chromosomal instability. , 2004, Oncogene.

[41]  Min-Liang Kuo,et al.  The Antiapoptotic Gene mcl-1 Is Up-Regulated by the Phosphatidylinositol 3-Kinase/Akt Signaling Pathway through a Transcription Factor Complex Containing CREB , 1999, Molecular and Cellular Biology.

[42]  J. Dewille,et al.  CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: I. "Loss of function" alterations in the c/EBPdelta growth inhibitory pathway in breast cancer cell lines. , 2004, Journal of Cellular Biochemistry.

[43]  Jen-kun Lin,et al.  Induction of apoptosis by hydroxydibenzoylmethane through coordinative modulation of cyclin D3, Bcl-X(L), and Bax, release of cytochrome c, and sequential activation of caspases in human colorectal carcinoma cells. , 2003, Journal of agricultural and food chemistry.

[44]  Kornelia Polyak,et al.  Molecular markers in ductal carcinoma in situ of the breast. , 2003, Molecular cancer research : MCR.

[45]  Amanda K. Pearce,et al.  Integrating stress-response and cell-cycle checkpoint pathways. , 2001, Trends in cell biology.

[46]  Wen‐Ming Yang,et al.  HDAC1/HDAC3 modulates PPARG2 transcription through the sumoylated CEBPD in hepatic lipogenesis. , 2008, Biochimica et biophysica acta.

[47]  A. Wendel,et al.  Sensitization by 5-Azacytidine toward Death Receptor-Induced Hepatic Apoptosis , 2009, Journal of Pharmacology and Experimental Therapeutics.

[48]  S. Minucci,et al.  Activation of Rac1 and the p38 Mitogen-activated Protein Kinase Pathway in Response to All-trans-retinoic Acid* , 2001, The Journal of Biological Chemistry.

[49]  Jen-kun Lin,et al.  Induction of apoptosis by 1-(2-hydroxy-5-methylphenyl)-3-phenyl-1,3-propanedione through reactive oxygen species production, GADD153 expression, and caspases activation in human epidermoid carcinoma cells. , 2005, Journal of agricultural and food chemistry.

[50]  H. Hsu,et al.  Epigenetic Silencing of CCAAT/Enhancer-binding Protein δ Activity by YY1/Polycomb Group/DNA Methyltransferase Complex* , 2008, Journal of Biological Chemistry.

[51]  A. Giordano,et al.  Rb family proteins as modulators of gene expression and new aspects regarding the interaction with chromatin remodeling enzymes , 2006, Oncogene.

[52]  H. Yang-Yen,et al.  Interleukin-3 Stimulation of mcl-1 Gene Transcription Involves Activation of the PU.1 Transcription Factor through a p38 Mitogen-Activated Protein Kinase-Dependent Pathway , 2003, Molecular and Cellular Biology.